Venmax Drugs And Pharmaceuticals Ltd (531015) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531015 | NSE: | Pharmaceuticals & Drugs | Small Cap

Venmax Drugs&Pharma Share Price

30.45 1.45 5.00%
as on 05-Dec'25 12:13

Venmax Drugs And Pharmaceuticals Ltd (531015) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531015 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Venmax Drugs&Pharma

Based on:

M-Cap below 100cr DeciZen not available

Venmax Drugs And Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
62.03
Market Cap:
21.2 Cr.
52-wk low:
6.9
52-wk high:
37

Is Venmax Drugs And Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Venmax Drugs And Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Venmax Drugs And Pharmaceuticals Ltd is a below average quality company.

2. Is Venmax Drugs And Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Venmax Drugs And Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Venmax Drugs And Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Venmax Drugs And Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Venmax Drugs&Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Venmax Drugs And Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -7.3%-140.9%0%0%0%0%0%0%0%-0.6%-
Value Creation
Index
-1.5NANANANANANANANANA-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1.90.300.20.50.20000.83
Sales YoY Gr.--86.5%-100%NA213.3%-63.8%-100%NANANA-
Adj EPS -0.3-1.4-0.5-0.5-0.5-0.33.50.40.1-00.5
YoY Gr.-NANANANANANA-87.8%-72.1%-116.7%-
BVPS (₹) 0.4-3.6-4-4.5-5-5.3-1.8-1.4-1.2-1.310.8
Adj Net
Profit
-0.1-0.7-0.2-0.2-0.3-0.21.90.20.1-00
Cash Flow from Ops. -0.2-1.1-0.3-0.1-0.30.31.9-00-2.3-
Debt/CF from Ops. -9.2-1.8-8-47.1-98.80.2-113.6160.1-0-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -9.2%11.5%NANA
Adj EPS NANA-117.8%-116.7%
BVPS-214.3%NANANA
Share Price 27.4% 48.8% 93.9% 341.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-51.589.112.210.6116-99.1-27.3-9.5-0.69.9
Op. Profit
Mgn %
-7.1-237.60-157.8-53.9-198.2000-131.3-21.5
Net Profit
Mgn %
-7.1-287.30-156.8-57.9-96.8000-1.311.2
Debt to
Equity
8.7-1-1-1-1-0.8-0.4-0.5-0.5-0.10
Working Cap
Days
4301,3030339219539000601778
Cash Conv.
Cycle
13930-85-55-72900081353

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 9.90%

Sales growth is good in last 4 quarters at 446.62%

Sales growth has been subdued in last 3 years 0.00%

Net Profit has been subdued in last 3 years -117.84%

Latest Financials - Venmax Drugs And Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 0.5 -
TTM Sales (₹ Cr.) 3.1 -
BVPS (₹.) 10.8 -
Reserves (₹ Cr.) 1 -
P/BV 2.69 -
PE 62.03 -
From the Market
52 Week Low / High (₹) 6.90 / 36.96
All Time Low / High (₹) 1.10 / 36.96
Market Cap (₹ Cr.) 21.2
Equity (₹ Cr.) 7.3
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Venmax Drugs&Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Venmax Drugs&Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Venmax Drugs&Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales1.930.2600.150.470.170000.81
Operating Expenses 2.070.870.230.390.730.500.130.190.101.87
Manufacturing Costs0000.010.01000.0100
Material Costs1.910.2400.090.320.290000.79
Employee Cost 0.040.060.050.100.220.060.010.030.020.04
Other Costs 0.120.570.180.190.180.140.120.150.081.03
Operating Profit -0.14-0.62-0.23-0.24-0.25-0.33-0.13-0.19-0.10-1.06
Operating Profit Margin (%) -7.1%-237.0%--157.0%-53.9%-198.0%----131.0%
Other Income 00.120000.181.980.420.201.05
Interest 000.010000000
Depreciation 0000.010.010.010.010.010.010.01
Exceptional Items 0-0.8400000000
Profit Before Tax -0.14-1.34-0.24-0.24-0.27-0.161.850.230.09-0.01
Tax 000-00.010000.02-0
Profit After Tax -0.14-1.34-0.24-0.24-0.27-0.161.850.230.06-0.01
PAT Margin (%) -7.1%-515.0%--156.0%-57.9%-96.8%----1.3%
Adjusted EPS (₹)-0.3-2.6-0.5-0.5-0.5-0.33.50.40.1-0.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 0.20-1.87-2.11-2.35-2.62-2.79-0.94-0.71-0.65-0.66
Share Capital 5.245.245.245.245.245.245.245.245.245.24
Reserves -5.04-7.11-7.35-7.59-7.86-8.03-6.18-5.95-5.89-5.90
Minority Interest0000000000
Debt1.721.852.042.242.522.330.350.350.350.05
Long Term Debt1.72000000000
Short Term Debt01.852.042.242.522.330.350.350.350.05
Trade Payables0.570.080.060.310.400.460.470.330.100.63
Others Liabilities -0.740.080.090.130.160.300.330.250.285.15
Total Liabilities 1.750.140.070.330.460.310.210.210.085.17

Fixed Assets

Gross Block0000.120.120.120.090.070.070.07
Accumulated Depreciation0000.010.020.030.0100.010.03
Net Fixed Assets 0000.110.100.090.080.070.070.04
CWIP 0000000000
Investments 0.01000000000
Inventories0000.110.2200000.06
Trade Receivables0.680000.040.040.040.0400.95
Cash Equivalents flag 0.0300000.080002.48
Others Assets 1.030.140.070.110.100.110.100.100.011.64
Total Assets 1.750.140.070.330.460.310.210.210.085.17

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -0.19-1.06-0.26-0.05-0.280.261.91-00-2.29
PBT -0.14-1.34-0.24-0.24-0.27-0.161.850.230.09-0.01
Adjustment 0-0.09000.010.010.010.010.010.03
Changes in Working Capital -0.050.37-0.010.19-0.030.420.05-0.24-0.07-2.3
Tax Paid 00000000-0.020
Cash Flow From Investing Activity 00.010-0.11000000
Capex 00.010-0.12000000
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity 0.221.020.260.160.28-0.19-1.98004.77
Net Proceeds from Shares 0000000005.07
Net Proceeds from Borrowing 00.130.190.160.2800000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0.220.890.0700-0.19-1.9800-0.30
Net Cash Flow 0.03-0.0300-00.07-0.07002.48

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-51.49N/AN/AN/AN/AN/AN/AN/AN/AN/A
ROCE (%)-7.34N/AN/AN/AN/AN/AN/AN/AN/AN/A
Asset Turnover Ratio0.840.2700.751.20.440000.31
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/A1.03-00N/A
Working Capital Days
Receivable Days780051681000431
Inventory Days000254124000026
Payable Days2114850734410537000168

Venmax Drugs And Pharmaceuticals Ltd Stock News

Venmax Drugs And Pharmaceuticals Ltd FAQs

The current trading price of Venmax Drugs&Pharma on 05-Dec-2025 12:13 is ₹30.45.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Venmax Drugs&Pharma stood at ₹21.15.
The latest P/E ratio of Venmax Drugs&Pharma as of 04-Dec-2025 is 62.03.
The latest P/B ratio of Venmax Drugs&Pharma as of 04-Dec-2025 is 2.69.
The 52-week high of Venmax Drugs&Pharma is ₹36.96 and the 52-week low is ₹6.90.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Venmax Drugs&Pharma is ₹3.06 ( Cr.) .

About Venmax Drugs And Pharmaceuticals Ltd

Venmax Drugs and Pharmaceuticals is a public limited company incorporated under Companies Act, 1956 and domiciled in India. The company was initially incorporated as private limited company under the name and style of ‘Yenkay Medico Private Limited’, on September 28, 1998. The company thereafter changed its name to ‘Yenkey Drugs & Pharmaceuticals Private Limited’ on January 18, 1995. The company has become a public limited company on February 3, 1995 with ‘Yenkey Drugs & Pharmaceuticals Ltd’. Finally, the company has changed its name to ‘Venmax Drugs & Pharmaceuticals Ltd’ on April 13, 2009.

The company is engaged in the business of pharmaceutical products, drug intermediates, and Active Pharmaceutical Ingredients (APIs). It is currently developing oncology products in its R&D division. The company is planning to establish a cGMP-compliant manufacturing unit in the Pharma Cluster at Hyderabad to meet export demand.

Business area of the company

Venmax Drugs and Pharmaceuticals is engaged in the business of pharmaceutical products, drug intermediates, and active pharmaceutical ingredients.

You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×